WIRE — Macquarie retained its Outperform rating on Cohance Lifesciences despite a weaker-than-expected June quarter, while Jefferies maintained Underperform as sales declines across businesses pushed EBITDA...
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.